小分子靶向药物研究湖南省重点实验室
 
 
 

 首页 | 实验室概况 | 科学研究 | 学术交流 | 信息公开 | 人才招聘 | 学校主页 | 科技处 | 医学院 

 
本栏热点文章
 
  文章详细页面
当前位置: 首页>>科学研究>>研究成果>>正文
 
20180427新增国际知名杂志论文
2018-04-29 09:00  

1. LICONG1,2*, SHUTING YANG3*, YONG ZHANG1JIANGUO CAO1 and XIAOHUA FU1. DFMG attenuates theactivation of macrophages induced by co‑culture with LPC‑injured HUVE‑12 cellsvia the TLR4/MyD88/NF‑κB signaling pathway. INTERNATIONAL JOURNAL OF MOLECULARMEDICINE 41: 2619-2628, 2018.(第二单位)

 

2. ZhirenWang,†,‡ Jinhui Hu, Xiaoping Yang,XingFeng, Xingshu Li,*,† Ling Huang,*,†and AlbertS. C. Chan. Design, Synthesis, and Evaluation of Orally BioavailableQuinoline−Indole Derivatives as Innovative Multitarget-Directed Ligands:Promotion of Cell Proliferation in the Adult Murine Hippocampus for theTreatment of Alzheimer's Disease. J. Med. Chem. 2018, 61, 1871−1894 .(第二单位)

 

3. TingTao1,2, Caimei He1,2, Jun Deng1,2, YanjunHuang1,2, Qiongli Su1,2, Mei Peng1,2,4, MeilingYi1,2, Kwame Oteng Darko1,2, Hui Zou1,2 andXiaoping Yang1,2,3.A novel synthetic derivative of quercetin,8-trifluoromethyl-3,5,7,3'4' -O-pentamethyl-quercetin, inhibits bladder cancergrowth by targeting the AMPK/mTOR signaling pathway. Oncotarget, 2017, Vol. 8,(No. 42), : 71657-71671.(第一单位)

 

4. QiongliSu1,2 , Ting Tao1,2 ,Lei Tang3,4 , Jun Deng1,2, Kwame Oteng Darko1,2 ,Sichun Zhou1,2 ,Mei Peng1,2,5, Shanping He6 , Qing Zeng3,4 , Alex F. Chen3,4,Xiaoping Yang1,2,6. Down-regulation of PKM2 enhancesanticancer efficiency of THP on bladder cancer.J Cell Mol Med. 2018;1–17. (第一单位)

 

关闭窗口
 
 
 
 
 网站地图 | 返回首页 | 联系我们 

Copyright 2018 湖南师范大学小分子靶向药物研究与创制实验室  地址:中国湖南长沙岳麓区桐梓坡路371号 邮编:410013